100. Nimesulide 100mg ER 28-03-08
For symptomatic treatment of acute rhinosinusitis
U.S FDA APPROVED DRUGS DURING 2004
211. Nimesulide Injection 75mg/ml 28-06-2004
For short term treatment of post-operative pain
246. Nimesulide Injection (100mg/ml) 08-10-2004
(Veterinary)
Veterinary use
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Nimesulide NSAID Jan 1995
2.Nimesulide 1.0%w/w 17-11-2009
+ Ethanol 31% w/w
Tropical solution
For the local application in releiving paining acute low backache,
Tendonitis, Tensosinovitis and sprains
3.Nimesulide 100mg ER 28-03-2008
+ Levocetrizine Hcl 5mg tablets
For symptomatic treatment of acute Rhinosimusitis
4.Nimesulide ER 200mg 18-05-2009
Addl.Indn.
Acute pain in orthopedic, ENT,Dental and Post operative pain
5.Nimesulide Injection 08-10-2004
100mg/ml
Veterinary
Veterinary use
6.Nimesulide injection 28-06-2004
75mg/ml
For short term treatment of post-operative pain
INFORMATION UPDATE-
NIMESULIDE BANNED-
Ireland, Singapore, and Nogeria and many other countries have banned the use of Nimesulide
due to unacceptable side effects.
The European Medicine Agency (EMA) has restricted the use of nimesilide in adults to
- Acute pain for short term use
- Osteoarthiritis and
- Dysmenorrehea only
It is not to be used for fever. The use in children is prohibited
Nimesulide was discovered by 3M Pharmaceuticals , a US company but its use is not permitted
in America.
It is also not approved for use in Britian, Canada, Sweden, Denmark, Australia, New Zealand,
Japan and 168 other countries.
In India Nimesulide is permitted to be sold (MIMS)
Manufacturer Details